| P2093 | author name string | Yan Gao | |
| | Hongwei Wang | |
| | Min Du | |
| | Xiaojun Wu | |
| | Zhengtao Wang | |
| | Yixin He | |
| | Hongshuai Liu | |
| P2860 | cites work | Emerging Therapies for Relapsing Multiple Sclerosis | Q22253063 |
| | A novel transcription factor, T-bet, directs Th1 lineage commitment | Q22253874 |
| | Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo | Q28253554 |
| | Glutamate and multiple sclerosis | Q28258908 |
| | Multiple sclerosis | Q28299151 |
| | Bax involvement in p53-mediated neuronal cell death | Q28510439 |
| | Current and emerging therapies in multiple sclerosis: a systematic review | Q29010983 |
| | The Bcl2 family: regulators of the cellular life-or-death switch | Q29614982 |
| | Mechanisms underlying inflammation in neurodegeneration | Q29617977 |
| | Neurodegenerative tauopathies | Q29619895 |
| | Microglia: a sensor for pathological events in the CNS | Q29620556 |
| | Astragaloside IV inhibits spontaneous synaptic transmission and synchronized Ca2+ oscillations on hippocampal neurons | Q33312341 |
| | Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitis | Q33903242 |
| | Increase in Th17 and T-reg lymphocytes and decrease of IL22 correlate with the recovery phase of acute EAE in rat. | Q34081554 |
| | T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire | Q34542240 |
| | Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity | Q34554148 |
| | Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients | Q34606170 |
| | The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy | Q35688436 |
| | Oxidative and antioxidative potential of brain microglial cells. | Q36237582 |
| | Multiple sclerosis--the plaque and its pathogenesis | Q36410882 |
| | Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps | Q37376117 |
| | Common themes emerge in the transcriptional control of T helper and developmental cell fate decisions regulated by the T-box, GATA and ROR families | Q37419449 |
| | The role of astragaloside in regeneration of the peripheral nerve system. | Q53646874 |
| | Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression | Q79248996 |
| | A model of experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice for the characterisation of intervention therapies | Q80262405 |
| | Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis | Q81470372 |
| | Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis | Q81489801 |
| | [Effect of ERK1/2 signaling pathway on astragaloside IV protects H9c2 cells against H2O2-induced oxidative injury] | Q82580007 |
| | Peripheral oxidative stress in relapsing-remitting multiple sclerosis | Q83436985 |
| | Evaluation of serum oxidant/antioxidant balance in multiple sclerosis | Q83748737 |
| | Astragaloside IV dilates aortic vessels from normal and spontaneously hypertensive rats through endothelium-dependent and endothelium-independent ways | Q83865856 |
| | Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale | Q84774058 |
| | The effect of Astragaloside IV on immune function of regulatory T cell mediated by high mobility group box 1 protein in vitro | Q84975984 |
| | Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. | Q37694644 |
| | Radical changes in multiple sclerosis pathogenesis | Q37769906 |
| | Neuroinflammation: modulation by flavonoids and mechanisms of action | Q37959586 |
| | Astragaloside IV prevents MPP⁺-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production | Q39406072 |
| | Protective effects of peroxiredoxin-1 at the injured blood-brain barrier | Q39985913 |
| | Molecular basis of anti-apoptotic effect of immunophilin ligands on hydrogen peroxide-induced apoptosis in human glioma cells | Q40534149 |
| | Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier | Q40928488 |
| | The role of p53 in cell cycle regulation | Q41176248 |
| | p53 expression in nitric oxide‐induced apoptosis | Q41428409 |
| | Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment. | Q41486306 |
| | Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. | Q42110512 |
| | Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. | Q42407979 |
| | Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease | Q42855049 |
| | Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation | Q43089679 |
| | Effects of astragaloside IV on myocardial calcium transport and cardiac function in ischemic rats. | Q44171971 |
| | Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study | Q44703173 |
| | Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia | Q44925844 |
| | Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis | Q45115027 |
| | Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture. | Q46028556 |
| | Induction of Bcl-2 and Bax was related to hyperphosphorylation of tau and neuronal death induced by okadaic acid in rat brain | Q46787321 |
| | Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption | Q48210868 |
| | Relationship between the clinical scoring and demyelination in central nervous system with total antioxidant capacity of plasma during experimental autoimmune encephalomyelitis development in mice | Q48342866 |
| | The activities of antioxidant enzymes and the level of malondialdehyde in cerebellum of rats subjected to methotrexate: protective effect of caffeic acid phenethyl ester | Q48526958 |
| | Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression | Q48874616 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| P304 | page(s) | e76495 | |
| P577 | publication date | 2013-10-04 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels | |
| P478 | volume | 8 | |